TAG:
analyzers
Roche, Digene, Centrex, Labtest.com, Specialty Labs, Tripath Imaging
By Robert Michel | From the Volume VIII No. #15 – November 5, 2001 Issue
ROCHE DIAGNOSTICS POSITIONED TO SERVE PUBLIC HEALTH LABS HEIGHTENED CONCERNS over bioterrorist attacks have accelerated plans within the public health lab sector to acquire state-of-the art diagnostic technology in DNA typing and enzyme immunoassay. Roche Diagnostics has in…
“September 4, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 12 – September 4, 2001 Issue
Here’s early warning: Medicare and Medicaid funding will become high-profile issues during 2002. Numbers just released by the Congressional Budget Office indicate that Medicare spending will increase by 10% during fiscal 2001 over fiscal 2000. Increased provider payments are contri…
“August 13, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 11 – August 13, 2001 Issue
In recent years he’s become an influential “behind the scenes” guy within the lab industry. Now Heywood D. Cochrane, Jr. is joining the Board of Directors at AmeriPath, Inc., based in Riviera Beach, Florida. Most laboratorians know Cochrane from his tour as President and CEO of…
Ortho-Clinical Diagnostics Embraces New Testing Technology
By Robert Michel | From the Volume VII No. 17 – December 4, 2000 Issue
CEO SUMMARY: Despite a decade of consolidation, competition among the world’s largest diagnostics manufacturers remains intense. In response to this competition, Ortho-Clinical Diagnostics (OCD) is preparing a variety of new products and services for its clinical laboratory customers. I…
Point-Of-Care Chemistry Ready To Transform Labs
By Robert Michel | From the Volume VI No. 16 – November 22, 1999 Issue
CEO SUMMARY: Following on the heels of our prediction about web-based test ordering/results reporting, here’s another equally revolutionary development. CARESIDE, Inc. is ready to launch a point-of-care instrument suite for routine, high-volume chemistry and hematology tests. Early peek…
West Hills Hospital Lab Hits Outreach Home Run
By Robert Michel | From the Volume VI No. 11 – August 9, 1999 Issue
CEO SUMMARY: Popular wisdom says that California’s managed care market is a financial disaster for clinical laboratories. Yet here’s an exciting story about a community hospital that launched a brand-new laboratory outreach program in 1997 and found solid success. During the last two …
Chiron Is Biotech Firm, Respected For Innovation
By Robert Michel | From the Volume V No. 13 – September 28, 1998 Issue
CEO SUMMARY: Chiron is respected for its leadership in branched DNA and viral load technologies. The company had high expectations for its diagnostics group, particularly after its purchase of Ciba Corning. But rapid consolidation of the diagnostics industry changed Chiron’s opportunity…
Bayer Acquires Chiron In Consolidation Move
By Robert Michel | From the Volume V No. 13 – September 28, 1998 Issue
CEO SUMMARY: As expected, consolidation within the diagnostics industry continues. This time it is Bayer, spending $1.1 billion to acquire Chiron’s diagnostics business. Once completed, Bayer will be the fourth-largest diagnostics company in the world. Laboratory customers of both firms…
Private Consortium Plans To Decode Human Genes
By Robert Michel | From the Volume V No. 8 – June 15, 1998 Issue
CEO SUMMARY: Five years ago, the only option for mapping was to involve the government. New advancements in technology have lowered costs so radically that now private companies are willing to use their own funds to map the human genome. This brings the day ever closer when genetics-based…
Rural Hospital Succeeds With Lab Outreach Service
By Robert Michel | From the Volume IV No. 14 – October 6, 1997 Issue
CEO SUMMARY: Laboratory administrators at rural hospitals generally believe there is no point in establishing a laboratory outreach program. Potential clients are few, and distances between small towns are great. But neither of these obstacles prevented Olympic Memorial Hospital from succ…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized